MCR4 agonist (Superluminal)

N/A

Report date: 2025/08/14 17:29:15
NME

Base Information

Drug NameMCR4 agonist (Superluminal)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsObesityBardet-Biedl Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuperluminal Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuperluminal Medicines Inc
Inactive CompaniesN/A
Active IndicationsObesityBardet-Biedl Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A